A Trial to Investigate the Efficacy and Safety of NW Low-Glu ® in Patients With Type II Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2 Interventions: Dietary Supplement: NW Low-Glu ®; Drug: Metformin Sponsors: Natural Wellness Egypt Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
A Phase III RCT to Investigate the Efficacy and Safety of NW Low-Glu ® in Patients With Type II Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2 Interventions: Dietary Supplement: NW Low-Glu ®; Drug: Metformin Sponsors: Natural Wellness Egypt Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
Conditions: Obesity; Liver Diseases; Liver Fibrosis; Liver Fat; NAFLD; Weight Loss; Insulin Resistance; Insulin Sensitivity; Insulin Sensitivity/Resistance; Metabolic Diseases; Diabetes; Diabetes Mellitus, Type 2; Diabetes Mellitus; NASH With Fibrosis; Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; Non-alcoholic Steatohepatitis Interventions: Device: ESG; Drug: GLP1-RA Sponsors: Pichamol Jirapinyo, MD, MPH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Assessment of Gastric Emptying by SHR20004 in Healthy Subjects
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: Acetaminophen/SHR20004; Drug: Acetaminophen/Placebo Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Postprandial Glucose Response Using Mass-Market No-Added-Sugar Ice Cream
Conditions: Type 2 Diabetes Interventions: Other: No-added-sugar ice cream; Other: Conventional products Sponsors: Dasman Diabetes Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
TeleCare North Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Other: Telemonitoring 1; Other: Telemonitoring 2 Sponsors: Aalborg University Hospital; Steno Diabetes Center Nordjylland; Aalborg University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Exercise Timing and the Circadian Clock in Individuals With Type 2 Diabetes and Those at Risk
Conditions: Diabetes Mellitus, Type 2 Interventions: Behavioral: HIIT Sponsors: Faculdade de Motricidade Humana; Funda ção para a Ciência e a Tecnologia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Chemerin, Fetuin-A, IL-34 and IL-13 Levels in Diabetic Periodontitis Patients
Conditions: Periodontitis; Diabetes Mellitus, Type 2 Interventions: Procedure: Non-Surgical Periodontal Treatment Sponsors: Marmara University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects
Conditions: Type 2 Diabetes Interventions: Drug: HRS-7535 Tablets Sponsors: Shandong Suncadia Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Conditions: Healthy; Type 2 Diabetes Mellitus Interventions: Drug: LY3938577; Drug: Placebo; Drug: Insulin degludec Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
The Effects of Upper Extremity Aerobic Exercise Training in Patients With Type 2 Diabetes
Conditions: Type2diabetes Interventions: Other: Upper extremity aerobic exercise training; Other: Control Group Sponsors: Gazi University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Cardio-metabolic Diseases in Immigrants and Ethnic Minorities: From Epidemiology to New Prevention Strategies
Conditions: Diabetes Mellitus, Type 2 Interventions: Other: Health promotion; Other: Usual care Sponsors: Azienda Ospedaliero-Universitaria Careggi; Azienda Ospedaliera Universitaria Renato Dulbecco; AUSL - IRCCS in Tecnologie Avanzate e Modelli Assistenziali in Oncologia di Reggio Emilia; Istituto Nazionale per la promozione della salute delle popolazioni Migranti e per il contrasto delle malattie della Povert à (INMP) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
Conditions: Chronic Kidney Disease; Type 2 Diabetes; Obesity Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Placebo Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy
Conditions: Peripheral Diabetic Neuropathy Interventions: Drug: Resveratrol, Alpha lipoic acid, Super oxide dismutase; Drug: Resveratrol; Drug: Alpha lipoic acid; Drug: Super Oxide Dismutase Sponsors: Khyber Medical University Peshawar Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes
Conditions: Diabetes Type 2; Hypertriglyceridemia; Diabetes Mellitus Interventions: Dietary Supplement: EPAVasc; Dietary Supplement: Corn Oil Sponsors: University of Ioannina; LIBYTEC Pharmaceutical S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
